HomeOwner SearchCategory Search
Visit USCOParkinson's Disease-Derived Fibroblasts Containing Mutations in SNCA, GBA and LRRK2 Show a Convergent Deregulated Cell Signaling Route through Ubiquitin-like ISG15
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
Parkinson's Disease-Derived Fibroblasts Containing Mutations in SNCA, GBA and LRRK2 Show a Convergent Deregulated Cell Signaling Route through Ubiquitin-like ISG15
Status
Published
on 31 Dec 2018
Year of Creation
2018
Copyright Claimant
Amanda L. Flores Torres
Registration Number
TX0008667206
on 31 Dec 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008667206) dated 31 Dec 2018, pertains to an electronic file (eService) titled "Parkinson's Disease-Derived Fibroblasts Containing Mutations in SNCA, GBA and LRRK2 Show a Convergent Deregulated Cell Signaling Route through Ubiquitin-like ISG15" created in 2018. The copyright holder is Amanda L. Flores Torres, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Amanda L. Flores Torres.
Application Details
Registration Number
TX0008667206
Registration Date
12/31/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Parkinson's Disease-Derived Fibroblasts Containing Mutations in SNCA, GBA and LRRK2 Show a Convergent Deregulated Cell Signaling Route through Ubiquitin-like ISG15
Author Statement: Amanda L. Flores Torres Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.